Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Offer for Subscription

30 Apr 2014 07:01

RNS Number : 8455F
Maven Income & Growth VCT PLC
30 April 2014
 



Maven Income and Growth VCT plc (the "Company")

 

Extension to Offer for Subscription

 

On 24 October 2013, the Company, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 4 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to £20 million (before issue costs) together with an over-allotment facility for up to a further £5 million, in aggregate (the "Offer").

 

The Offer closed on 5 April 2014 in relation to the tax year 2013/14 and was intended to close on 30 April 2014 in relation to the tax year 2014/15 unless fully subscribed by an earlier date or previously extended by the directors of the Company (the "Directors") to no later than 30 September 2014.

 

The Finance Bill 2014 (the "Bill"), published on 27 March 2014, contained proposed changes to regulations which would apply to VCT shares issued on or after 6 April 2014. The Directors have been advised that certain provisions of the Bill are ambiguous and, if an allotment were to be made subsequent to 6 April 2014, could be interpreted in a manner that would have serious and adverse tax consequences for all Shareholders. Although HM Treasury have acknowledged the concerns made by the VCT industry regarding these provisions, and have agreed that amendments will be made to them, the relevant amendments have not yet been published. Any amendments will also be subject to Parliamentary review and debate.

 

Therefore, in the interest of all of the Company's Shareholders, the Directors have decided to postpone any allotment of new Ordinary Shares under the Offer for the 2014/15 tax year, with applications (and application monies) held pending until the Directors believe that there is certainty that allotments can take place without contravening the new rules. At such time when the Directors have been advised that the allotments can be made without adverse effects on the status and operation of the Company, an appropriate announcement will be made.

 

Given that the Directors intended to allot Ordinary Shares for the tax year 2014/15 before the end of April 2014, it was the expectation that all new investors under the Offer would be eligible to receive the final dividend from the Company for the year ended 28 February 2014. However, in view of the above, it is possible that any further allotment of new Ordinary Shares may now take place after the record date for this dividend, in which case the Offer Price will be adjusted under the Pricing Formula for the Offer and will reflect that no dividend payment will be received.

 

In view of the above, the Offer has been extended to 5.00 pm on 30 September 2014 or such earlier date on which the Offer is fully subscribed or on which the directors of the Companies may resolve to close the Offer. In relation to this issue, it is also proposed that a Supplementary Prospectus will be submitted to the UKLA for approval, at which point a further announcement will be made.

 

Any enquiries in respect of this extension to the Offer should be directed to:

 

Maven Capital Partners UK LLP:

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRFKLLLZZFFBBD
Date   Source Headline
28th Jan 202511:25 amRNSDirector/PDMR Shareholding
28th Jan 202510:39 amRNSIssue of Equity
24th Jan 202511:32 amRNSNet Asset Value(s)
29th Nov 20249:33 amRNSIssue of Equity - Dividend Investment Scheme
26th Nov 20243:51 pmRNSStatement re Dividend Investment Scheme
14th Nov 20242:51 pmRNSResult of General Meeting
24th Oct 20247:00 amRNSHalf-year Report
17th Oct 20244:27 pmRNSTransaction in Own Shares
16th Oct 20244:59 pmRNSTransaction in Own Shares
14th Oct 20243:25 pmRNSUnaudited Net Asset Value and Interim Dividend
27th Sep 20244:31 pmRNSPublication of a Prospectus
5th Sep 20244:45 pmRNSUnaudited Net Asset Value
19th Jul 20242:25 pmRNSIssue of Equity - Dividend Investment Scheme
18th Jul 20244:16 pmRNSTransaction in Own Shares
17th Jul 20245:03 pmRNSTransaction in Own Shares
15th Jul 20243:07 pmRNSStatement re Dividend Investment Scheme
15th Jul 20242:23 pmRNSStatement re Dividend Investment Scheme
12th Jul 20242:56 pmRNSNet Asset Value(s)
11th Jul 20241:38 pmRNSResult of AGM
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
31st May 20244:16 pmRNSFinal Results
16th May 20243:13 pmRNSTransaction in Own Shares
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.